Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
About Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
Rigshospitalet Glostrup is located in the township of Glostrup 8 km from the center of Copenhagen in Denmark. It is owned and managed by the regional health authority of the Greater Copenhagen region, Region Hovedstaden.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Clinical Trials at Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
During the past decade, Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
2014-10-06
2018-01-23
Terminated
975
Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT)
2016-07-21
2018-01-31
Terminated
994
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
2018-10-09
2021-08-27
Completed
951
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)
2019-03-11
2022-01-07
Completed
658
A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration
2021-04-19
2024-08-09
Active, not recruiting
1,036
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
According to Clinical.Site data, the most researched conditions in "Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning" are
"Geographic Atrophy" (2 trials), "Diabetic Macular Edema" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Wet Macular Degeneration" (1 trials). Many other conditions were trialed in "Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning" in a lesser frequency.
Clinical Trials Intervention Types at Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
Most popular intervention types in "Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning" are "Drug" (5 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Lampalizumab" (2 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
The vast majority of trials in "Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning" are
5 trials for "All" genders.
Clinical Trials Status at Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning
Currently, there are NaN active trials in "Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Rigshospitalet Glostrup; Afdeling for Øjensygdomme, Center for Forskning, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".